SLC25A37: Potential Drug Target Or Biomarker (G51312)

Target Name: SLC25A37

NCBI ID: G51312

SLC25A37

SLC25A37: Potential Drug Target Or Biomarker

SLC25A37 (Pro2217) is a protein that is expressed in various tissues throughout the body. It is a member of the SLC family, which is known for its ability to transport a wide variety of molecules across cell membranes. One of the most interesting aspects of SLC25A37 is its potential as a drug target or biomarker.

SLC25A37 has been shown to play a role in a number of important biological processes. For example, it is involved in the regulation of ion channels, which are responsible for allowing and preventing the flow of electrical currents through cells. SLC25A37 has also been shown to be involved in the transport of molecules that are involved in cell signaling, such as neurotransmitters and hormones.

One of the potential benefits of targeting SLC25A37 as a drug or biomarker is its potential to modulate a wide range of cellular processes. For example, SLC25A37 has been shown to be involved in the regulation of muscle contractions, which could make it a potential target for drugs that are intended to treat muscle-related conditions such as muscle weakness or spasticity.

SLC25A37 may also be a useful biomarker for certain types of cancer. For example, it has been shown to be expressed in a number of different types of cancer, including breast, lung, and ovarian cancer. This suggests that it may be a useful indicator of the presence of these types of tumors in the body.

Another potential application of SLC25A37 as a drug target is its potential to treat certain neurological conditions. For example, SLC25A37 has been shown to be involved in the regulation of ion channels in the brain, which could make it a potential target for drugs that are intended to treat conditions such as epilepsy or Parkinson's disease.

In addition to its potential as a drug target or biomarker, SLC25A37 is also of interest to researchers because of its structure and biology. SLC25A37 is a member of the SLC family, which is known for its ability to transport a wide variety of molecules across cell membranes. This suggests that it may have a similar mechanism of transport, and may be able to interact with similar molecules. This could make it a useful model for studying the transport of other molecules across cell membranes.

Overall, SLC25A37 is a protein that has a wide range of potential applications as a drug target or biomarker. Its involvement in the regulation of ion channels and its expression in various tissues make it an attractive candidate for study. Further research is needed to fully understand the biology and potential applications of SLC25A37.

Protein Name: Solute Carrier Family 25 Member 37

Functions: Mitochondrial iron transporter that specifically mediates iron uptake in developing erythroid cells, thereby playing an essential role in heme biosynthesis

The "SLC25A37 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC25A37 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets